LUGFRINSS: Lung Ultrasound-guided Fluid Resuscitation in Neonatal Septic Shock

Sponsor
Guangdong Second Provincial General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT06144463
Collaborator
(none)
72
1
3
17.9
4

Study Details

Study Description

Brief Summary

object name: Lung ultrasound-guided fluid resuscitation in neonatal septic shock.

type of study: prospective observational study. goal of study: The effects of severe ultrasound-assisted fluid resuscitation and conventional fluid resuscitation on the prognosis of children with neonatal septic shock were compared to evaluate the application value of the two techniques in fluid resuscitation of neonatal septic shock.

research design: In this study, children with neonatal septic shock diagnosed in the neonatal intensive care unit of the Second People 's Hospital of Guangdong Province from January 1,2022 to December 31,2023 were included in the population. According to the different monitoring methods used in conventional / clinical shock treatment, 30 cases of fluid resuscitation assisted by severe ultrasound, 30 cases of fluid resuscitation assisted by NICOM and 30 cases of conventional fluid resuscitation were collected, a total of 90 cases.

( 1 ) The demographic data, blood examination and microbiological examination data of the two groups at admission were collected.

( 2 ) The fluid volume, blood lactic acid, blood pressure, vasoactive drugs ( such as dopamine and epinephrine / norepinephrine ), mechanical ventilation, renal replacement therapy and antibiotic use were collected before fluid resuscitation.

( 3 ) The cumulative fluid infusion volume during fluid resuscitation ( 6 hours ), and the use of vasoactive drugs and mechanical ventilation for 6 hours were collected.

( 4 ) NICU hospitalization time, cumulative hospitalization time and mortality were collected.

Data collection :

( 1 ) The demographic data, blood examination and microbiological examination data of the three groups at admission were collected.

( 2 ) The fluid volume, blood lactic acid, blood pressure, vasoactive drugs ( such as dopamine and adrenaline / norepinephrine ), mechanical ventilation, renal replacement therapy and antibiotic use before fluid resuscitation were collected.

( 3 ) The cumulative fluid infusion volume during fluid resuscitation ( 6 hours ), and the use of vasoactive drugs and mechanical ventilation for 6 hours were collected.

( 4 ) NICU hospitalization time, cumulative hospitalization time and mortality were collected.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: lung ultrasound-guided fluid resuscitation
N/A

Detailed Description

Efficacy evaluation: The main efficacy criteria: NICU hospitalization time and cumulative hospitalization time, mortality. Secondary efficacy criteria: cumulative fluid volume during fluid resuscitation (6 hours), and use of vasoactive drugs and mechanical ventilation for 6 hours.

Study Design

Study Type:
Interventional
Actual Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Study on the Application Value of Fluid Resuscitation Guided by Lung Ultrasound in Neonatal Septic Shock
Actual Study Start Date :
Jan 1, 2022
Actual Primary Completion Date :
May 31, 2023
Actual Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control group

No intervention will be given

Sham Comparator: traditional group

Non-invasive cardiac output monitoring ( NICOM ) assisted fluid resuscitation.

Diagnostic Test: lung ultrasound-guided fluid resuscitation
For the LUGFR group, therapy was applied based on the same treatment guidelines, and initial lung ultrasonography was performed after enrollment as baseline assessment of lung. The lung ultrasound was conducted using the Doppler ultrasound diagnostic instrument (Philips CX50) at a probe frequency range of 8 to 12 MHz. Lung ultrasonography was conducted using the 12-region method that included the anterior, lateral, and posterior walls on both sides of the lung, which was focused on the condition of A-lines, B-lines (including confluent B-line and compact B-lines), lung consolidation and pleural effusion

Experimental: LUGFR group

lung ultrasound-guided fluid resuscitation

Diagnostic Test: lung ultrasound-guided fluid resuscitation
For the LUGFR group, therapy was applied based on the same treatment guidelines, and initial lung ultrasonography was performed after enrollment as baseline assessment of lung. The lung ultrasound was conducted using the Doppler ultrasound diagnostic instrument (Philips CX50) at a probe frequency range of 8 to 12 MHz. Lung ultrasonography was conducted using the 12-region method that included the anterior, lateral, and posterior walls on both sides of the lung, which was focused on the condition of A-lines, B-lines (including confluent B-line and compact B-lines), lung consolidation and pleural effusion

Outcome Measures

Primary Outcome Measures

  1. hospitalization time [Within 2 weeks]

    Primary indicator

  2. mortality [Within 2 weeks]

    Primary indicator

Secondary Outcome Measures

  1. Cumulative fluid volume [Within 2 weeks]

    Secondary Outcome

  2. Use of vasoactive drugs [Within 2 weeks]

    Secondary Outcome

  3. Use of mechanical auxiliary gas [Within 2 weeks]

    Secondary Outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 28 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Born less than 28 days on admission ;

  2. In line with the diagnostic criteria for neonatal septic shock in the ' 2020 International Guidelines for Saving Sepsis Campaign : Management of Sepsis-related Organ Dysfunction in Children ' ;

  3. For children diagnosed with septic shock, fluid resuscitation should be performed according to the routine diagnosis and treatment.

  4. The legal guardian has signed the informed consent.

Exclusion Criteria:
  1. combined with neurogenic shock, trauma and hemorrhagic shock ;

  2. symptomatic patent ductus arteriosus ;

  3. combined with congenital heart disease ;

  4. give up treatment or death within 24 hours of admission ;

  5. The legal guardian refused to participate in the study ;

  6. Key information and information missing.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Guangdong Second Provincial General Hospital Guangzhou Guangdong China 510317

Sponsors and Collaborators

  • Guangdong Second Provincial General Hospital

Investigators

  • Study Director: Zhenyu Liang, Master, Department of Pediatrics, Guangdong Second Provincial General Hospital, Guangzhou, China

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Dabin Huang, Doctor, Guangdong Second Provincial General Hospital
ClinicalTrials.gov Identifier:
NCT06144463
Other Study ID Numbers:
  • DHuang
First Posted:
Nov 22, 2023
Last Update Posted:
Nov 28, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dabin Huang, Doctor, Guangdong Second Provincial General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 28, 2023